ARCHIVES

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Hospices Urges To Develop Program For AIDs Victims; Companies Give $25,5000 To NCI Fund

October 25, 1985

HEW To Pay All Care Cost At 26 Hospices

January 11, 1980

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003

Adriamycin Update Discussed At Seminar

January 10, 1975

NIH Programs: Varmus Appoints 20 To Council of Public Representatives

April 30, 1999

In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs

September 15, 1995